RecruitingNCT06907329
The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders.
Phase not reported · 126 planned enrolment
- Countries listed
- 1
- Registry update
- July 8, 2025
